Kyle Fahrbach
AuthID: R-00H-V8S
1
TITLE: Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison
AUTHORS: Cruz, Francisco; Danchenko, Natalya; Fahrbach, Kyle; Freitag, Andreas; Tarpey, Jialu; Whalen, John;
PUBLISHED: 2023, SOURCE: JOURNAL OF MEDICAL ECONOMICS, VOLUME: 26, ISSUE: 1
AUTHORS: Cruz, Francisco; Danchenko, Natalya; Fahrbach, Kyle; Freitag, Andreas; Tarpey, Jialu; Whalen, John;
PUBLISHED: 2023, SOURCE: JOURNAL OF MEDICAL ECONOMICS, VOLUME: 26, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Indirect comparison of patisiran and tafamidis for treatment of hereditary transthyretin- mediated (hATTR) amyloidosis with polyneuropathy Full Text
AUTHORS: Teresa Coelho; Michael Polydefkis; Hollis Lin; Jared Gollob; Sonalee Agarwal; Marissa Betts; Kyle Fahrbach; Madhura Chitnis; Violaine Plante Bordeneuve;
PUBLISHED: 2018, SOURCE: Annual Meeting of the Peripheral-Nerve-Society in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, VOLUME: 23, ISSUE: 4
AUTHORS: Teresa Coelho; Michael Polydefkis; Hollis Lin; Jared Gollob; Sonalee Agarwal; Marissa Betts; Kyle Fahrbach; Madhura Chitnis; Violaine Plante Bordeneuve;
PUBLISHED: 2018, SOURCE: Annual Meeting of the Peripheral-Nerve-Society in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, VOLUME: 23, ISSUE: 4
INDEXED IN: WOS
WOS